期刊文献+

HPLC法测定阿利吉仑片的含量

Determination of Aliskiren Tablets by HPLC
下载PDF
导出
摘要 目的:采用HPLC法测定阿利吉仑片的含量。方法:采用XBridge C18(4.6 mm×250 mm,5μm)色谱柱,流动相为甲醇-水(用磷酸调pH为3.0)(40∶60),流速为1.0 mL/min,检测波长为280 nm,柱温为30℃。结果:阿利吉仑的线性范围为70~120μg/mL;3批样品中阿利吉仑含量分别为150.12、150.26、150.04 mg/片。结论:本法简便、准确、适合于阿利吉仑片含量测定。 Objective: To establish an HPLC method for quantitative determination of Aliskiren Tablets. Methods: The analytical column was XBridge C18(4.6mm×250mm,5μm) column. The mobile phase was composed of methanol and water (with phosphoric acid pH=3.0) (40 : 60) at a flow rate of 1.0 mL/min. The wavelength of UV detector was 280 mn and column temperature was 30℃. Results: The linear range of Aliskiren was 70-120 μg/mL. The contents of Aliskiren in three batches of samples were 150.12, 150.26, 150.04 mg/tablet..Conclusion: This method is convenient, accurate and suitable to determine the content of Aliskiren Tablets.
出处 《广东化工》 CAS 2013年第12期214-214,213,共2页 Guangdong Chemical Industry
关键词 阿利吉仑片 HPLC法 含量测定 Aliskiren tablets HPLC method content determination
  • 相关文献

参考文献4

二级参考文献34

  • 1Staessen JA,Li Y,Richart T.Oral renin inhibitors[J].Lancet,2006,368(9545):1449-1456.
  • 2de Gasparo M,Cumin F,Nussberger J,et al.Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers[J].Br J Clin Pharmacol,1989,27(5):587-596.
  • 3Wood JM,Schnell CR,Cumin F,et al.Aliskiren,a novel,orally effective renin inhibitor,lowers blood pressure in marmosets and spontaneously hypertensive rats[J].J Hypertens,2005,23(2):417-426.
  • 4Azizi M,Webb R,Nussberger J,et al.Renin inhibition with aliskiren:where are we now,and where are we going?[J].J Hypertens,2006,24(2):243-256.
  • 5Zhao C,Vaidyanathan S,Yeh CM,et al.Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus[J].Clin Pharmacokinet,2006,45(11):1125-1134.
  • 6Nussberger J,Wuerzner G,Jensen C,et al.Angiotensin Ⅱ suppression in humans by the orally active renin inhibitor Aliskiren (SPP100):comparison with enalapril[J].Hypertension,2002,39(1):E1-E8.
  • 7O'Brien E,Barton J,Nussberger J,et al.Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic,an angiotensinconverting enzyme inhibitor,or an angiotensin receptor blocker[J].Hypertension,2007,49(2):276-284.
  • 8Villamil A,Chrysant SG,Calhoun D,et al.Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide[J].J Hypertens,2007,25(1):217-226.
  • 9Pool JL,Schmieder RE,Azizi M,et al.Aliskiren,an orally effective renin inhibitor,provides antihypertensive efficacy alone and in combination with valsartan[J].Am J Hypert ens,2007,20 (1):11-20.
  • 10Sealey JE,Laragh JH.Aliskiren,the first renin inhibitor for treating hypertension:reactive renin secretion may limit its effectiveness[J].Am J Hypertens,2007,20(5):587-597.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部